TheJobsMapAbcuro jobs and careers
Newton, MA, United States
About Abcuro
Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class anti-KLRG1 antibody designed to deplete cytotoxic T cells that attack healthy muscle tissue in patients with inclusion body myositis (IBM), into clinical studies.
Founded in 2015 by Stefano Gullà.
- Founded
- 2015
- Employees
- 11 to 50
- Total funding
- $214.8M
- Headquarters
- Newton
Leadership
The top of Abcuro's org chart, with how many people report into each leader.
Alex Martin
Chief Executive Officer
43 reports
H. Jeffrey Wilkins, MD
Chief Medical Officer
16 reports
Karen Tubridy
Chief Operating Officer
16 reports
George Eldridge
Chief Financial Officer
6 reports
Courtney Cupples
Chief Commercial Officer (CCO)
Jeff Geary
Director, Human Resources
Board
Steven A Greenberg
Chief Scientific Advisor and Chair, Medical Advisory Board
Jay Knowles
Director
Jason P. Hafler
Director
Tomer Kariv
Director
Dietmar Berger
Observer
Yajun Xu
Observer
Jobs at Abcuro
No open positions right now. Explore more companies on TheJobsMap.